Elevance Health Inc.
General ticker "ELV" information:
- Sector: Health Care
- Industry: Health Care Providers & Services
- Capitalization: $83.6B (TTM average)
Elevance Health Inc. does not follow the US Stock Market performance with the rate: -36.2%.
Estimated limits based on current volatility of 1.2%: low 328.72$, high 336.70$
Factors to consider:
- Company included in S&P500 list
- Company pays dividends (quarterly): last record date 2025-09-10, amount 1.71$ (Y2.05%)
- Total employees count: 104200 as of 2024
- Top business risk factors: Healthcare cost pressures, Economic downturns and volatility, Cybersecurity threats, Regulatory and compliance, Pandemic risks
- Price in estimated range
- Earnings for 9 months up through Q3 are close to our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [319.73$, 479.62$]
- 2025-12-31 to 2026-12-31 estimated range: [322.52$, 481.63$]
Financial Metrics affecting the ELV estimates:
- Negative: with PPE of 11.2 at the end of fiscal year the price was very high
- Positive: -3.60 < Operating profit margin, % of 4.47
- Positive: Inventory ratio change, % of -0.03 <= 0
- Positive: Interest expense per share per price, % of 1.38 <= 3.41
- Negative: Industry operating profit margin (median), % of 1.70 <= 2.97
- Positive: 1.87 < Return on assets ratio (scaled to [-100,100]) of 4.86
- Negative: Industry inventory ratio change (median), % of 0.29 > 0.28
- Positive: 18.93 < Shareholder equity ratio, % of 35.35 <= 41.86
- Negative: Industry operating cash flow per share per price (median), % of 4.26 <= 5.52
- Negative: Investing cash flow per share per price, % of -6.01 <= -4.48
Short-term ELV quotes
Long-term ELV plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $156,595.00MM | $171,340.00MM | $177,011.00MM |
| Operating Expenses | $148,995.00MM | $163,625.00MM | $169,107.00MM |
| Operating Income | $7,600.00MM | $7,715.00MM | $7,904.00MM |
| Interest Expense | $851.00MM | $1,030.00MM | $1,185.00MM |
| Income(Loss) | $7,600.00MM | $7,715.00MM | $7,904.00MM |
| Taxes | $1,712.00MM | $1,724.00MM | $1,933.00MM |
| Profit(Loss)* | $5,894.00MM | $5,987.00MM | $5,980.00MM |
| Stockholders Equity | $36,243.00MM | $39,306.00MM | $41,315.00MM |
| Assets | $102,755.00MM | $108,928.00MM | $116,889.00MM |
| Operating Cash Flow | $8,399.00MM | $8,061.00MM | $5,808.00MM |
| Capital expenditure | $1,152.00MM | $1,296.00MM | $1,256.00MM |
| Investing Cash Flow | $-4,560.00MM | $-5,572.00MM | $-5,167.00MM |
| Financing Cash Flow | $-1,318.00MM | $-3,349.00MM | $1,193.00MM |
| Earnings Per Share** | $24.56 | $25.69 | $25.68 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.